Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on February 1, 2007

Published online before print November 1, 2006
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.0506311v1
81/2/449    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fuhler, G. M.
Right arrow Articles by Vellenga, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fuhler, G. M.
Right arrow Articles by Vellenga, E.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0506311


Received for publication May 9, 2006.
Revised September 20, 2006.
Accepted for publication September 21, 2006.


Article

The reduced GM-CSF priming of ROS production in granulocytes from patients with Myelodysplasia is associated with an impaired lipid raft formation

Gwenny M. Fuhler *, Nel R. Blom *{dagger}, Paul J. Coffer {ddagger}, A. Lyndsay Drayer {sect}, and Edo Vellenga *@

*Division of Hematology, Department of Medicine, University Medical Center Groningen, Groningen, the Netherlands; {dagger}Laboratory of Cell Biology and Electron Microscopy, University of Groningen, Groningen, the Netherlands; {ddagger}Department of Immunology, University Medical Center Utrecht, Utrecht, the Netherlands; and {sect}Sanquin Blood Bank North East Netherlands, Groningen, the Netherlands

@ To whom correspondence should be addressed. E-mail: E.Vellenga{at}int.umcg.nl.


   Abstract

Patients with Myelodysplasia show an impaired reactive oxygen species (ROS) production in response to fMLP stimulation of GM-CSF-primed neutrophils. In this study, we investigated the involvement of lipid rafts in this process and showed that treatment of neutrophils with the lipid raft-disrupting agent methyl-{beta}-cyclodextrin abrogates fMLP-induced ROS production and activation of ERK1/2 and protein kinase B/Akt, two signal transduction pathways involved in ROS production in unprimed and GM-CSF-primed neutrophils. We subsequently showed that there was a decreased presence of Lyn, p91phox, and p22phox in lipid raft fractions from neutrophils of Myelodysplastic syndromes (MDS). Furthermore, the plasma membrane expression of the lipid raft marker GM1, which increases upon stimulation of GM-CSF-primed cells with fMLP, was reduced significantly in MDS patients. By electron microscopy, we showed that the fMLP-induced increase in GM1 expression in GM-CSF-primed cells was a result of de novo synthesis, which was less efficient in MDS neutrophils. Taken together, these data indicate an involvement of lipid rafts in activation of signal transduction pathways leading to ROS production and show that in MDS neutrophils, an impaired lipid raft formation in GM-CSF-primed cells results in an impaired ROS production.

Key Words: MDS • signal transduction • NADPH




This article has been cited by other articles:


Home page
BloodHome page
G. M. Fuhler, A. L. Drayer, S. G. M. Olthof, J. J. Schuringa, P. J. Coffer, and E. Vellenga
Reduced activation of protein kinase B, Rac, and F-actin polymerization contributes to an impairment of stromal cell derived factor-1 induced migration of CD34+ cells from patients with myelodysplasia
Blood, January 1, 2008; 111(1): 359 - 368.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the Society for Leukocyte Biology.